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Abstract 42 
Background: Berry fruit have been shown to convey a number of benefits in animal models; 43 
including improvements in cognitive performance, slowing of cognitive decline and 44 
neuroprotection. These findings, along with epidemiological evidence and data showing 45 
modulation of factors related to brain function, suggest a potential role for berry 46 
polyphenols in improving cognitive performance.  47 
Objective: The current study assessed the effects of two blackcurrant extracts on cognitive 48 
outcomes, mood, blood glucose profile and peripheral monoamine levels. Anthocyanin 49 
bioavailability was also assessed.  50 
Design: A randomised, double-blind, placebo-controlled, crossover study was conducted in 51 
36 healthy young participants (18-35y). Following a 10 minute baseline assessment, 52 
participants consumed sugar, flavour and colour matched drinks containing no polyphenols 53 
(control) or 525 +/- 5mg of polyphenols per 60kg body weight from either an anthocyanin 54 
enriched powdered blackcurrant extract (DelcyanTM) or cold pressed blackcurrant juice 55 
(cultivar Blackadder) in counterbalanced order on separate days. A 70-minute computerised 56 
cognitive assessment (COMPASS) designed to be attentionally demanding and mentally 57 
fatiguing was then completed following a 60-minute resting absorption period. Blood 58 
platelet monoamine oxidase-B (MAO-B), plasma anthocyanin levels, plasma prolactin and 59 
plasma monoamines and associated metabolites were also investigated in a subsection of 60 
the cohort at 2.5 hours post-consumption. 61 
Results: When compared to control, both blackcurrant extracts improved attention task 62 
performance. The juiced extract reduced reaction times during the digit vigilance task, 63 
whereas the powdered extract increased accuracy during a rapid visual information 64 
processing task. Following the juiced Blackadder extract, platelet MAO-B was inhibited by 65 
96%, dihydroxyphenylglycol (DHPG) was reduced and normetadrenalin was increased in 66 
blood plasma, and a rapid decline in blood glucose levels was significantly attenuated, when 67 
compared to control.  68 
Conclusion: This is the first illustration of a cognitive benefit of acute blackcurrant 69 
supplementation in healthy young humans and the first description of a clinically significant 70 
inhibition of MAO-B and MAO-A using a commonly consumed fruit. These data also illustrate 71 
that compounds other than anthocyanins are important to observe in vivo MAO inhibition 72 
and that the degree of processing and cultivar of blackcurrant fruit used substantially alters 73 
the neuroendocrinological and cognitive benefits conveyed. 74 
  75 
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Introduction 76 
Epidemiological evidence suggests a relationship between flavonoid intake and cognitive 77 
decline/dementia [1, 2], with a specific benefit indicated for berries (strawberry and 78 
blueberry) that was not observed with other individual foods (Devore et al. 2012). Support 79 
for this comes from literature demonstrating a slowing or reversal of natural cognitive 80 
decline in berry-fed rats. Several different mechanisms of action have been proposed and 81 
investigated in an attempt to explain improvements to memory in animal models, including 82 
anti-inflammatory and antioxidant responses and improvements to neural signalling (see 83 
Spencer 2010 for review). Of particular relevance to the current study, anthocyanins, their 84 
aglycones and phenolic acid metabolites have been shown to have monoamine oxidase 85 
(MAO) inhibitory effects in vitro. As MAO metabolises monoamines, inhibition of this 86 
enzyme could reduce oxidative stress associated with this process and lead to increased 87 
levels of these neurotransmitters, essential for normal cognitive function. Indeed MAO-B 88 
inhibitors are used in the treatment of neurodegenerative symptoms associated with 89 
Parkinson’s disease. The use of MAO-A inhibitors for several decades in the treatment of 90 
mood disorders also suggests that this inhibition, if demonstrated in vivo, could lead to 91 
enhanced mood [3, 4]. 92 
Only three published peer reviewed intervention studies have demonstrated positive 93 
effects of berry consumption on human behaviour, impacting verbal memory and spatial 94 
memory after supplementation of concord grape juice [5, 6] and blueberry juice [7] in adults 95 
with age related memory decline. There is, however, no published evidence pertaining to 96 
modulation of cognitive performance in healthy young adults.  97 
One naturally rich source of anthocyanins that has been neglected in the literature is 98 
blackcurrant (Ribes nigrum). Intact glucosides, galactosides and arbinosides of the berry 99 
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anthocyanins and their associated metabolites have been found at levels ranging from 0.2 to 100 
1.5ng/L in the blood and urine of humans after oral ingestion of flavonoid rich berries such 101 
as blackcurrants, blueberries and boysenberries [3, 4]. Bioavailability of these compounds is, 102 
therefore, low. As well as anthocyanins, blackcurrant also contains an abundance of other 103 
phenolic structures in smaller quantities, which are able to exert physiological changes, such 104 
as the rate and pattern of glucose uptake from the small intestine [8-10], and improved 105 
vascular function [11] and gut microbiota profile [12], which all have the potential to 106 
modulate human behaviour.  107 
 The aim of the present study was to explore the effects of acute supplementation of 108 
two blackcurrant extracts, with matched quantities of polyphenols and sugars but differing 109 
phenolic profiles, on attention, subjective mood, peripheral monoamines, prolactin and 110 
blood glucose. Anthocyanin bioavailability was also assessed at 2.5 hours post-dose in 111 
plasma.  112 
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Materials and methods 113 
Participants 114 
Thirty six participants were recruited from Auckland, New Zealand using opportunity 115 
sampling and received $120NZ to recompense them for any expense they may have 116 
incurred to participate in the trial. Before participants were enrolled in the study they 117 
attended a 90 minute screening session. During this session, participants gave their written 118 
informed consent to participate in the study and were screened for any contraindications to 119 
the study. In brief, all participants reported themselves to be healthy, not pregnant, non-120 
tobacco users. Participants were not using dietary supplements or prescribed, over the 121 
counter or recreational drugs (excluding the contraceptive pill), did not have any 122 
sensitivities to any of the study treatments and had a body mass index below 35kg/m2. 123 
Participants also completed three repetitions of the study day tasks to ensure they met the 124 
required minimum standards (internally set) to participate in the study and to minimise 125 
practice effects. 126 
Treatments 127 
Participants received three treatment drinks in an order dictated by random allocation to a 128 
counterbalancing (Williams Latin Square) schedule with at least one week washout between 129 
visits. Extracts were assessed for the phytochemical constituents using the method 130 
described by Schrage et al [13]. Anthocyanin stability of the Blackadder juice extract at -20 131 
degrees was confirmed via HPLC. Over the eight week period no significant loss due to 132 
storage was observed. Intervention drinks contained either 0mg of polyphenols (control) or 133 
525±5mg of polyphenols per 60kg of bodyweight from an anthocyanin enriched 134 
blackcurrant extract, (1.66g of Just the Berries, New Zealand (DelcyanTM)) or from 142ml of a 135 
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cold pressed blackcurrant fruit juice, (Blackadder cultivar, cultivated and processed by Plant 136 
and Food Research Ltd, New Zealand (Blackadder juice)). One hundred and forty two 137 
millilitres of juice was yielded from approximately 150g of fresh fruit, an amount which 138 
could realistically be consumed in one serving. The phytochemical content of each 139 
treatment can be seen in table 1. The Blackadder juice was frozen in 50ml aliquots at -20°C 140 
until the day of use. The naturally occurring sugars in the Blackadder juice were quantified 141 
via HPLC and the same levels were supplemented to the control and DelcyanTM treatments. 142 
The total volume of the drink was then made up to 200ml (for a 60kg person) with cold 143 
drinking water. All drinks quantities were calculated per kilo of body weight resulting in 144 
differing volumes. In each case all drinks contained; 0.78g of glucose, 0.13g of fructose, 145 
0.09g of Splenda® sweetener and 3.34µl blackcurrant flavouring (NI #12220, Formula foods 146 
NZ) per kilogram of bodyweight. Drinks were coded and prepared fresh from frozen each 147 
morning by a third party who had no further part in the running of the study. No member of 148 
the investigation team was aware of the coding of the drinks until a blind-data review was 149 
completed.  150 
7 
 
Table 1: Phytochemical constituents of Blackadder juice (mg/100ml of raw juice & mg supplemented per 60kg 
of body weight) and DelcyanTM extract (mg/g of raw powder & mg supplemented per 60kg of body weight) 
Compound 
Blackadder juice 
mg/100ml 
DelcyanTM extract 
mg/g 
Blackadder juice 
mg/60kg 
DelcyanTM extract 
mg/60kg  
Caffeoyl quinate 6.3 0.1 9 0.1 
Caffeic acid glucoside 1.9 0.2 2.4 0.0 
p-Coumaroyl quinate 3.6 0.4 5.4 0.7 
Epigallocatechin 8.6 0 12 0 
Delphinidin glucoside 24.1 44.6 34.2 73.8 
Delphinidin rutinoside 115.9 107.4 164.4 178.2 
Cyanidin glucoside 13.6 28.8 19.2 47.4 
Cyanidin rutinoside 150.9 149 214.2 247.2 
Myricetin rutinoside 15.6 4.5 22.2 7.2 
Myricetin glucoside 2.1 0 3 0 
Quercetin rutinoside 3.4 1.2 4.8 1.8 
Quercetin glucoside 1.9 2.3 2.4 3.6 
Quercitin pentoside 1.4 5.5 1.8 9 
Myricetin 0.2 0.6 0.0 0.6 
Vitamin C 168 0 100.8 0 
 151 
Cognitive and mood measures 152 
All cognitive measures and mood scales were delivered using the Computerised Mental 153 
Performance Assessment System (COMPASS, University of Northumbria), a purpose 154 
designed software application for the flexible delivery of randomly generated parallel 155 
versions of standard and novel cognitive assessment tasks, which has previously been 156 
shown to be sensitive to a range of nutritional interventions [14-16]. For the purpose of 157 
behavioural analysis, three tasks were selected with the intention that attention 158 
performance and cognitive flexibility could be assessed. Seven repetitions of the digit 159 
vigilance task, Stroop task and rapid visual information task were completed in a fashion 160 
similar to that of the cognitive demand battery [17] where subsequent repetitions of a ten 161 
minute battery are shown to incrementally induce mental fatigue. Mood scales were used 162 
at baseline, between each post-dose repetition of digit vigilance, Stroop and rapid visual 163 
information tasks and at the end of the cognitive tasks. The logical reasoning task was used 164 
at baseline and after the attentionally demanding cognitive battery to assess executive 165 
functioning. 166 
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Study tasks                          167 
Digit vigilance: The digit vigilance task is a measure of sustained attention involving accurate 168 
selection of target stimuli. It focuses on alertness and vigilance while placing minimal 169 
demands on two other components of attention: selectivity and capacity. A single target 170 
digit was randomly selected and constantly displayed to the right of the screen. A series of 171 
single digits were presented in the centre of the screen at the rate of 80 per minute. The 172 
participant was required to press the response key on the computer keyboard as quickly as 173 
possible every time the digit in the series matched the target digit. The task lasted two 174 
minutes and there were 30 stimulus-target matches. Task outcomes were accuracy (%), 175 
reaction time for correct responses (msec) and number of incorrect responses (false 176 
alarms). 177 
Stroop: The Stroop test is a measure of attention, inhibition and cognitive flexibility. 178 
Participants were presented with a colour name. The colour name presented was written in 179 
a coloured ink which could be the same as the colour name or different. Participants had to 180 
respond to the colour of the ink using the peripheral mouse and corresponding colour 181 
response buttons. Participants were presented with 60 stimuli. Task measures were 182 
accuracy (percent correct) and reaction time (msec).  183 
Rapid visual information processing (RVIP): The RVIP task is a measure of sustained 184 
attention and working memory. The participant was required to monitor a continuous series 185 
of digits for targets of three consecutive odd or three consecutive even single digits. The 186 
single digits were presented at the rate of 100 per minute and the participant responded to 187 
the detection of a target string by pressing the response key on the computer keyboard as 188 
quickly as possible. The task was continuous and lasted for 5 minutes, with 8 correct target 189 
strings being presented in each minute. The task was scored for percentage of target strings 190 
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correctly detected, average reaction time for correct detections (msec), and number of 191 
incorrect responses (false alarms). 192 
Logical reasoning: The logical reasoning test requires the participant to think 193 
logically and analytically and is a measure of cognitive flexibility. A series of statements 194 
referring to the relationships between two letters appeared on the screen one at a time 195 
(e.g. “a precedes b: ba”). Participants were required to decide if each statement correctly 196 
described the order of the 2 letters that followed it by pressing the designated response 197 
keys on the computer keyboard. There were 24 stimuli. Mean reaction times were 198 
measured in msec, and accuracy of responses were recorded as percentages. 199 
Mood 200 
Bond-Lader visual analogue scales: Bond-Lader visual analogue mood scales [18] which have 201 
been shown to be sensitive to a number of nutritional intervention studies  were employed 202 
[14-16]. The reliability and validity of these visual analogue scales has been demonstrated 203 
[19]. The scales comprise a total of sixteen 100mm lines anchored at either end by 204 
antonyms (e.g. alert-drowsy, calm-excited) on which participants mark their current 205 
subjective position. Scores from the 16 Bond-Lader visual analogue scales were combined as 206 
recommended by the authors to form three mood factors: ‘alert’, ‘calm’ and ‘content’ [18]. 207 
Visual analogue scales: Following each repetition of the attentional demand battery, 208 
participants were asked to subjectively rate how mentally fatigued they felt and how 209 
difficult they found the cognitive tasks. The electronic visual analogue scales were anchored 210 
“not at all” on the left hand side of the scale and “extremely” on the right, with higher 211 
scores representing more mental fatigue/higher difficulty. 212 
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Study procedure 213 
Each participant was required to attend a total of three study days which were conducted at 214 
least seven days apart to ensure a sufficient wash out between conditions. During the week 215 
before, and throughout their participation in the study, participants were asked to abstain 216 
from berry consumption. Cognitive testing took place in a laboratory with participants 217 
visually and auditorily isolated from each other. On arrival at their first session, participants 218 
were randomly allocated to a treatment regime using a Latin square design that 219 
counterbalanced the order of treatments across the three active days of the study. On all 220 
three study days participants arrived at the lab in the morning (8:30am), after an overnight 221 
fast, and firstly gave a 10ml venous blood sample. Heart rate, blood pressure and blood 222 
glucose were then measured. Participants then completed one repetition of the ten minute 223 
baseline cognitive assessment comprising of the digit vigilance task, the Stroop task, the 224 
RVIP task, mood scales and the logical reasoning task. This constituted the baseline measure 225 
for that day. Participants were then supplemented with one of the study treatments in the 226 
form of a drink, which they were given five minutes to consume. Drinks were served chilled 227 
and in a dark brown 300ml plastic bottle with a straw to minimise the possibility of the 228 
participant recognising subtle differences in taste, look and mouth-feel between the 229 
treatments. After a 60 minute resting absorption period, in which participants read in a 230 
waiting area, participants’ blood pressure and heart rate were measured again and a second 231 
blood glucose reading was taken by finger prick. Participants then completed the post-dose 232 
cognitive assessment 65 minutes post consumption of the study treatments, a time when 233 
anthocyanins are known to be detectable in plasma after blackcurrant consumption [20]. 234 
This paradigm consisted of seven repetitions of the attention tasks (digit vigilance, Stroop, 235 
RVIP) and mood scales. This lasted 70 minutes and was followed by the logical reasoning 236 
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central executive task. Participants then gave a third blood pressure reading and a third 237 
blood glucose reading before providing a second and final venous blood sample. A diagram 238 
of the study visit running order can be seen in figure 1. 239 
The study received ethical approval from the New Zealand Regional Northern X Ethics board 240 
and was conducted according to the Declaration of Helsinki (1964).  241 
(Place figure 1 here) 242 
Biochemical analysis 243 
Venous blood samples (2x5ml) were collected at baseline and 150 minutes after 244 
supplementation of treatments, which coincided with the end of the tasks. Samples were 245 
collected in 5ml BD vacutainers© (Becton, Dickinson and company, Plymouth, New 246 
Zealand). Both receptacles were treated with anticoagulants, one with lithium heparin (LH) 247 
and one with ethylenediaminetetraacetic acid (EDTA). 248 
Whole blood samples treated with LH were immediately centrifuged (4°C, 5000rpm, 249 
10 minutes) (Hitachi Himac preparative ultracentrifuge model CP100MX). Plasma was then 250 
extracted and aliquoted into 1ml eppendorf© tubes. Aliquots were spiked with 200µl of 5% 251 
trifluorocetic acid for the purpose of measuring plasma anthocyanin content. Plasma 252 
samples were stored at -80°C until analysis was performed.  253 
Whole blood samples treated with EDTA were used to isolate blood platelets using 254 
the method reported by Snell et al [21].  Three and a half millilitres of whole blood were 255 
added to 2ml of phosphate buffered saline (PBS) containing 2g of glucose per litre of 256 
solution (PBS solution) and gently inverted. The solution was then centrifuged at (22°C, 257 
600g, 3 minutes) and the supernatant placed on ice. The volume of the residual red cell 258 
pellet was restored to 7ml with PBS solution, gently inverted to mix and centrifuged again 259 
12 
 
(22°C, 600g at 22°C, 3 minutes); the supernatant was removed and pooled with the first 260 
supernatant fraction. This procedure was performed 5 times. The pooled supernatant 261 
fractions were then centrifuged (4°C, 2000g, 10 minutes) and decanted leaving the platelet 262 
pellet which was stored at -80ºC until the MAO-B analysis was performed. 263 
Monoamine oxidase-B (MAO-B) activity analysis 264 
A subset of eight participants provided sufficient blood samples for all the study time points 265 
to allow for MAO-B analysis. 266 
The isolated platelet pellet was slowly thawed on ice, re-suspended in 1ml of PBS 267 
solution, sonicated with a probe sonicator (Microson ultrasonic cell disruptor, model 268 
XL2005) for 15 seconds on ice and centrifuged (4°C, 36,000g, 10 minutes) at. Sonication and 269 
centrifugation were then repeated after which the supernatant was removed and the pellet 270 
consisting of lysed platelets was re-suspended in sodium phosphate buffer. The protein 271 
concentration of the lysed platelet solution was determined against a bicinchoninic acid 272 
standard curve by using the Pierce BCA protein assay (ThermoFischer Scientific New Zealand 273 
Ltd) as per manufacturer’s instructions. Each sample was measured in triplicate and the 274 
average protein concentration was used. The lysed platelet solution was re-suspended in 275 
sodium phosphate buffer to a final concentration of 150µg/ml of protein.  276 
Determination of MAO-B activity was conducted using the Amplex® Red Monoamine 277 
Oxidase-B Assay Kit (A12214 Invitrogen), as per manufacturer’s instructions. One hundred 278 
microlitres of the diluted lysed platelet solution was added to a 96 well plate in triplicate. 279 
Two microlitres of the MAO-A inhibitor clorgyline were then added to each well that 280 
contained platelet membranes and incubated for 30 minutes at room temperature. During 281 
the incubation, 100µl of H2O2 standards and the negative control were then added to the 282 
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micro-plate in triplicate. After the 30 minute incubation, 100µl of the amplex red working 283 
solution were added to each well. The plate was immediately placed into the microplate 284 
reader (FLUOstar Omega Plate reader, BMG labtech) and set to incubate at 37°C with an 285 
excitation wavelength of 530-560nm and an emission wavelength of 590nm. The micro-286 
plate reader was programmed to take a reading every five minutes for one hour (13 287 
readings in total). The 30 minute reading was used to compare platelet MAO-B activity 288 
between treatments.  289 
Glucose 290 
Blood glucose was measured with the use of an Accu-Check (Roche Healthcare, NZ) blood 291 
glucose monitor via a finger prick blood sample at baseline, 60 minutes and 150 minutes 292 
post supplementation. All 35 participants who completed the study gave all required finger 293 
prick blood samples. 294 
Prolactin analysis 295 
Prolactin was measured by diagnostic Medlab, Auckland, New Zealand. Prolactin was 296 
analysed in 300μL of blood plasma collected in LH treated vacutainers. Due to technical 297 
issues, only 20 sets of blood samples were available for prolactin analysis (8 control, 7 298 
DelcyanTM, 5 Blackadder juice). For this reason, prolactin analysis was between subjects. 299 
LCMS analysis 300 
The phytochemical composition of the blackcurrant extracts (Blackadder juice, DelcyanTM ) 301 
and the control sample were determined by liquid chromatography mass spectrometry 302 
(LCMS) using a Shimadzu 2020 single-quadrupole mass spectrometer coupled to a Shimadzu 303 
20-Series UFLC system (Auckland, New Zealand) using the method described by Schrage et 304 
al [13]. 305 
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Levels of anthocyanins and monoamines in plasma at defined time points 306 
throughout the study were determined by LCMS using a 5500 QTrap triple 307 
quadrupole/linear ion trap (QqLIT) mass spectrometer equipped with a TurboIon-SprayTM 308 
interface (AB Sciex, Concord, Ontario, Canada) coupled to an Ultimate 3000 UHPLC (Dionex, 309 
Sunnyvale, California, USA). 310 
LCMS materials 311 
Formic acid (Riedel-de Haën), ammonium formate and acetic anhydride (Fluka), and Hunig’s 312 
base were purchased from Sigma Aldrich (Auckland, New Zealand). Optima LC/MS grade 313 
acetonitrile (Fisher Scientific) was purchased from ThermoFisher (Auckland, New Zealand). 314 
Water was of Milli-Q grade. Analytical standards, dopamine, normetadrenalin, noradrenalin, 315 
adrenalin, 3,4-dihydroxyphenylglycol (DHPG), serotonin and homovanillic acid (HVA) were 316 
purchased from Sigma-Aldrich, phenylethylamine (PEA) from Acros Organics (Geel, 317 
Belgium), cyanidin 3-glucoside, cyanidin 3-rutinoside, delphinidin 3-glucoside and 318 
delphinidin 3-rutinoside from Polyphenols Laboratories (Sandnes, Norway) and malvidin 3-319 
galactoside chloride from Extrasynthese (Genay Cedex, France). Deuterated acetic 320 
anhydride [d6] was purchased from Sigma-Aldrich and deuterated dopamine [d4] from CDN 321 
Isotopes (Quebec, Canada). Phree™ Phospholipid removal plates were purchased from 322 
Phenomenex (Torrance, CA, USA).  323 
Anthocyanin analysis in plasma 324 
A subset of 17 participants provided sufficient blood samples for all of the study time points 325 
for anthocyanin analysis to be conducted. 326 
Plasma samples (1ml) were further acidified (1:4 6N HCl:5% formic acidaq, 250µl) and 327 
then spiked with malvidin galactoside (5ng) as an internal standard. Samples were 328 
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centrifuged (4°C, 16100 RCF, 5 minutes) and proteins removed by precipitation via addition 329 
of acetone (1:3) to an aqueous aliquot (600µl). The samples were then chilled at -80°C for 30 330 
minutes prior to re-centrifuging (4°C, 16,100 RCF, 5 minutes) and the acetone removed via 331 
evaporation. Further clean-up to minimise the presence of phospholipids was achieved via 332 
liquid-liquid partition with hexane versus the aqueous sample. A final protein precipitation 333 
cleanup of the aqueous aliquot (400µl) with chloroform was performed prior to centrifuging 334 
(4oC, 16100 RCF, 5 minutes). Two hundred microlitres of the aqueous phase was transferred 335 
to an autosampler vial for immediate analysis by LCMS. 336 
Anthocyanin separation was achieved on a Zorbax SB-C18 Rapid Resolution HD 337 
2.1x100mm ID 1.8 micron column (Agilent Technologies, Santa Clara, CA, USA) maintained 338 
at 70°C. Solvents were (A) 5:3:92 acetonitrile/formic acid:water v/v/v and (B) 99.9:0.1 339 
acetonitrile/formic acid v/v and the flow rate was 600μL/min. The initial mobile phase, 340 
100% A was held isocratically for 0.5 minutes, then ramped linearly to 10% B at 5 minutes, 341 
followed by another linear ramp to 90% B at 5.1 minutes and held for 1.9 minutes before 342 
resetting to the original conditions. Sample injection volume was 20μl. MS data was 343 
acquired in the positive mode using a multiple reaction monitoring (MRM) method. The 344 
transitions monitored (Q1 and Q3), along with their optimised parameters (declustering 345 
potential (DP), entrance potential (EP), collision energy (CE) and collision cell exit potential 346 
(CXP)) are listed in Table 2.  347 
Table 2: Multiple reaction monitoring transitions used for blackcurrant anthocyanins 348 
Q1 Q3 Name DP EP CE CXP 
465 303 Delphinidin glucoside 70 10 30 10 
611 303 Delphinidin rutinoside 130 10 50 30 
449 287 Cyanidin glucoside  110 10 35 20 
595 287 Cyanidin rutinoside 50 10 55 1 
493 331 Malvidin galactoside (IS) 50 10 45 25 
 349 
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Other operating parameters were as follows: dwell time, 100ms; ionspray voltage, 350 
2500V; ion source temperature, 700°C; ion source gas one, 60psi; ion source gas two, 90psi 351 
and curtain gas, 40psi. 352 
Quantification was performed using the internal standard ratio method using 353 
MultiQuant software v3.0 (AB Sciex).   354 
Monoamine analysis in plasma 355 
Eight monoamines were analysed by LCMS from blood plasma following derivatisation. 356 
These were; serotonin, dopamine, phenylethylamine, adrenalin, noradrenalin, 357 
normetadrenalin, 3,4-dihydroxyphenylglycol (DHPG) and homovanillic acid (HVA). 358 
Plasma samples were treated to remove proteins and phospholipids and derivatised 359 
in two stages to acetylate alcohol and amine functional groups and alkylate free carboxylic 360 
acids with Hunig’s base prior to LCMS analysis. A double derivatisation was found to be 361 
necessary to acetylate the less reactive alkyl hydroxyl groups. The schematic in figure 2 362 
summarises the derivatisation of the different functional groups and the synthesis and use 363 
of labelled internal standards for each analyte to facilitate quantitation and to correct for 364 
matrix effects during analysis. 365 
(Place figure 2 here) 366 
Briefly, each plasma sample (200µl) was added to an individual well of a Phree™ 367 
Phospholipid removal plate already containing cold 600µl acetonitrile, 100µl acetic 368 
anhydride and 1ng dopamine-d4 [internal standard (IS)]. The Phree™ plate was centrifuged 369 
at 500g for 30 minutes, a further 200µl acetonitrile added to each well, and the plate 370 
centrifuged at 500g for a further 10 minutes. The filtrate was transferred to a 2ml micro 371 
tube, 100µl acetic anhydride added and heated at 50oC. After 30 minutes 20µl Hunig’s base 372 
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was added to each sample, vortexed then heated for a further 60 minutes. Samples were 373 
then evaporated to near dryness with nitrogen at 40oC. Samples were re-derivatised; 100µl 374 
acetonitrile, 100µl acetic anhydride and 10µl Hunig’s base heated for 40 minutes at 50oC. 375 
Finally, to each sample 1ng of the derivatised labelled internal standard monoamine mixture 376 
(d-IS) was added, and the sample made up to 1ml with water and transferred to an 377 
autosampler vial ready for analysis. 378 
Monoamine separation was achieved on an Atlantis® T3 150x2.1mm 3 micron 379 
column (Waters Corp., Milford, MA, USA), maintained at 40oC. Solvents were (A) MilliQ 380 
water +0.03% ammonium formate + 0.1 % formic acid and (B) acetonitrile + 0.1 % formic 381 
acid and the flow rate was 0.6ml/min. The initial mobile phase, 98% A, was held for 4 382 
minutes then ramped linearly to 70% A at 11 minutes, 20% A at 14 minutes, and 0% A at 383 
14.5 minutes and held for 5 minutes before resetting to the original conditions. Sample 384 
injection volume was 100µl.  385 
MS data was acquired in the positive mode using a scheduled MRM method. In some 386 
cases the ammonium adduct was the most abundant ion observed for Q1. The transitions 387 
monitored (Q1 and Q3), along with their optimised DP, EP, CE and CXP parameters are listed 388 
in Table 3.   389 
Table 3 Multiple reaction monitoring transitions used for monoamines and their isotopically labelled internal standard 390 
analogues 391 
Q1 Q3 Time Name DP EP CE CXP 
164 105 10.6 PEA  30 10 25 10 
167 105 10.6 PEA [d3] 30 10 25 10 
280 137 11.1 Dopamine  70 6.1 35 15 
289 139 11.1 Dopamine [d9] 70 6.1 35 15 
284 141 11.1 Dopamine [d4] 70 10 37 15 
293 143 11.1 Dopamine [d4] [d9] 70 10 37 15 
261 160 11.1 Serotonin  10 5 25 1 
267 161 11.1 Serotonin [d6] 10 5 25 1 
250 166 11.6 Normetadrenalin 50 9 25 15 
256 168 11.5 Normetadrenalin [d9] 50 9 25 15 
355 194 11.6 Noradrenalin 10 10 30 1 
367 199 11.5 Noradenalin [d12] 10 10 30 1 
292 250 12.5 Adrenalin  170 10 20 1 
301 257 12.5 Adrenalin [d12] 170 10 20 1 
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356. 237 13.4 DHPG  90 13 20 20 
368 244 13.3 DHPG [d12] 90 13 20 20 
308 224 13.9 HVA  110 10 25 20 
311 225 13.9 HVA [d3] 110 10 25 20 
 392 
Other operating parameters were as follows: ionspray voltage, 2500V; ion source 393 
temperature, 700°C; ion source gas one, 40psi; ion source gas two, 50psi and curtain gas, 394 
50psi. 395 
Quantification was performed using the internal standard ratio method using 396 
MultiQuant software v3.0 (AB Sciex).   397 
Statistics 398 
Mood, cognitive scores and the physiological measures were analysed as ‘change from 399 
baseline’ using the SPSS 18 statistics package. Baseline differences were calculated for all 400 
measures using a one way (treatment) ANOVA. 401 
Two way repeated measures ANOVAs (General linear model) (Treatment [control, 402 
DelcyanTM, juice] X completion [1 to 7] for attentional tasks and visual analogue scale 403 
outcomes OR Treatment [control, DelcyanTM, juice] X completion [1 to 2] for blood glucose 404 
and Bond-Lader) were conducted. Logical reasoning performance, platelet Monoamine 405 
Oxidase B activity, plasma monoamines and plasma anthocyanins levels were analysed by 406 
one-way (treatment) repeated measures ANOVA. Blood plasma prolactin was analysed 407 
using a one way (treatment) between subjects ANOVA. In all instances Mauchly`s test of 408 
sphericity was used to assess equality of the variances of the differences between factors. 409 
Where sphericity had been violated, Huynh-Feldt corrections for non-sphericity were 410 
implemented. Pairwise comparisons were conducted on all treatment-related effects with a 411 
p value <0.05 on the initial ANOVA to ascertain any differences between treatments for the 412 
whole session or, in the case of interactions, at each task repetition. Partial Bonferroni 413 
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corrections were applied to protect for error against multiple comparisons, therefore, the p 414 
value was multiplied by the number of treatments being compared to control. All post hoc p 415 
values are reported after corrections for multiple comparisons have been applied (x3 for 416 
anthocyanins and MAO-B and x2 for all other comparisons). 417 
Results 418 
Prior to analysis of change from baseline data, mean pre-dose scores for all three 419 
treatments (control, DelcyanTM, Juice) for each outcome were subjected to a one way 420 
repeated measures ANOVA. The only significant difference found was between active 421 
treatments for homovanillic acid. Data tables for all outcomes can be found in the 422 
supplementary materials. 423 
Cognitive performance 424 
A one way ANOVA was conducted on control change from baseline scores for the outcome 425 
fatigue to ensure the sustained attention cognitive paradigm was indeed mentally fatiguing. 426 
A significant effect of repetition [F(6,192)=16.44. p<0.0001] confirmed that each subsequent 427 
repetition of the tasks caused an increase in rating of mental fatigue.  428 
Digit vigilance 429 
There was a significant treatment × repetition interaction on digit vigilance reaction time [F 430 
(12,384)=1.82 p=0.044] without any effect upon accuracy. Pairwise comparisons revealed an 431 
increase in speed of response after supplementation of the juice treatment at repetition 1 432 
(p=0.028), 4 (p=0.011) and 7 (p=0.038). See Figure 3a. There were no effects on any digit 433 
vigilance outcomes after supplementation with DelcyanTM. 434 
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RVIP 435 
There was a significant main effect of treatment on RVIP accuracy [F (2,62)=5.87, p=0.005]. 436 
Pairwise comparisons showed an attenuation in the reduction of RVIP accuracy after 437 
supplementation of the DelcyanTM extract when compared to control (p=0.011), irrespective 438 
of repetition. There were no significant effects on reaction time or false alarms. See Figure 439 
3b. There were no effects on any RVIP outcomes after supplementation with juice.  440 
(Place figure 3 here) 441 
Blood glucose 442 
There was a significant main effect of treatment on blood glucose [F(2,68)=8.89, p<0.001]. 443 
Pairwise comparisons showed significantly higher blood glucose levels following 444 
supplementation of the juice treatment when compared to control (p=0.002), irrespective 445 
of repetition. See figure 4a. There were no significant effects following supplementation of 446 
DelcyanTM. 447 
Platelet MAO-B 448 
There was a significant effect of treatment on blood platelet MAO-B activity [F (2,16)=15.20 449 
p<0.001]. Pairwise comparisons showed a decrease in platelet MAO-B activity after 450 
supplementation with the juice treatment when compared to control (p<0.001). See figure 451 
4b. There were no significant differences between active treatment groups. There was no 452 
effect of the DelcyanTM treatment on blood platelet MAO-B. 453 
Monoamines 454 
The repeated measures ANOVA revealed a significant effect of treatment [F (2,32)=12.18 455 
p<0.001] on plasma levels of normetadrenalin. Pairwise comparisons showed levels of 456 
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normetadrenalin were significantly higher after supplementation of the juice treatment 457 
when compared to the control (p<0.001) and DelcyanTM (p<0.001). There were no effects of 458 
DelcyanTM. See figure 4c. 459 
The repeated measures ANOVA revealed a significant main effect of treatment [F 460 
(2,32)=21.30 p<0.001] on plasma levels of DHPG. Pairwise comparisons revealed levels of 461 
DHPG were significantly higher after supplementation of the juice treatment when 462 
compared to the control (p<0.001) and DelcyanTM (p<0.001). There were no effects of 463 
DelcyanTM versus control. See figure 4d. 464 
(Place figure 4 here) 465 
Blood plasma anthocyanin levels 466 
The repeated measures ANOVA revealed a significant effect of treatment on plasma levels 467 
of CY-GLU, CY-RUT, DEL-GLU and DEL-RUT [F(2,34)=27.5 (p<0.001)], [F(2,34)=33.7 468 
(p<0.001)], [F(2,34)=112.51 p<0.001), [F(1.45,25.25)=96.26 p<0.001) respectively. 469 
Plasma CY-GLU, CY-RUT, DEL-GLU and DEL-RUT levels were significantly higher after 470 
supplementation with the DelcyanTM treatment when compared to control (p<0.001, 471 
p=0.005, p<0.001, p<0.001) and the Blackadder juice treatment (p<0.001, p<0.001, p<0.003, 472 
p<0.001) respectively. 473 
Plasma CY-GLU, CY-RUT, DEL-GLU and DEL-RUT levels were also significantly higher 474 
after supplementation of the Blackadder juice treatment when compared to control 475 
(p<0.001), (p<0.001), (p=0.003) and (p<0.001) respectively. A graphical representation of 476 
anthocyanin levels in blood plasma can be seen in figure 5a. 477 
Following supplementation, the repeated measures ANOVA revealed a significant 478 
effect of the treatment on combined levels of CY-GLU, CY-RUT, DEL-GLU and DEL-RUT in 479 
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blood plasma (combined anthocyanin level is the total amount of anthocyanins measured in 480 
blood plasma after supplementation of the study treatment) after consumption of the study 481 
treatments, [F (2,32)=105.34, p<0.0001]. Pairwise comparisons revealed that combined 482 
anthocyanin levels were significantly higher after consumption of the DelcyanTM (p<0.001) 483 
and juice (p<0.001) treatment when compared to control. Levels were also significantly 484 
higher after supplementation of the DelcyanTM extract when compared to the Blackadder 485 
juice extract (p<0.001). A graphical representation of combined anthocyanin levels in blood 486 
plasma can be seen in figure 5b. 487 
 488 
(Place figure 5 here) 489 
 490 
. 491 
 492 
  493 
Table 3  Means and SD for the amount of measured anthocyanins given to the participants and the amount found in blood 
plasma (change from baseline) 150 minutes post supplementation of the DelcyanTM and Blackadder juice treatments 
Treatment Anthocyanin 
Amount supplemented 
mg/kilo body weight 
Amount 
supplemented 
mg/60kg of body 
weight 
Average amount in 
plasma (nM) 
DelcyanTM 
Cyanidin glucoside 0.8 48 0.4 ± 0.3 
Delphinidin glucoside 1.2 73.8 1.3 ± 0.9 
Cyanidin rutinoside 4.1 247.2 8.6 ± 2.9 
Delphinidin rutinoside 2.9 178.2 11.7 ± 4.5 
Blackadder 
juice 
Cyanidin glucoside 0.3 19.2 0.2 ± 0.1 
Delphinidin glucoside 0.5 34.2 0.8 ± 0.6 
Cyanidin rutinoside 3.5 214.2 6.4 ± 2.3 
Delphinidin rutinoside 2.7 164.4 7.8 ± 2.5 
Control 
Cyanidin glucoside 0 0 0.0 ± 0.1 
Delphinidin glucoside 0 0 0.0 ± 0.01 
Cyanidin rutinoside 0 0 0.0 ± 0.1 
Delphinidin rutinoside 0 0 0.0 ± 0.1 
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Discussion and conclusion 494 
The current study has outlined evidence of positive modulation of behaviour following 495 
administration of two blackcurrant extracts when compared to control, with no negative 496 
effects of either active extract. Improvements in RVIP accuracy were found after 497 
supplementation of the DelcyanTM extract and improvements in reaction time on the digit 498 
vigilance task were found after supplementation of the Blackadder juice extract. Although 499 
there were no other significant effects on behaviour, the Blackadder juice treatment 500 
demonstrated a number of physiological effects not present following DelcyanTM. These 501 
comprised of an inhibition of platelet MAO-B activity (96%) and a significant reduction in 502 
plasma normetadrenalin (60%) and increase in DHPG (~35.5%) when measured 2.5 hours 503 
after supplementation. The Blackadder blackcurrant juice treatment also showed a 504 
significantly sustained (over both time points) increased blood glucose when compared to 505 
control at 60 and 150 minutes, despite being sugar matched.  506 
An increase in accuracy was shown during the RVIP task after supplementation with 507 
the DelcyanTM treatment, irrespective of task repetition, with no evidence of slowed 508 
reaction times. In regards to the juice treatment, there was evidence of an attenuation of 509 
the increase of digit vigilance reaction times seen with repeated testing, with no evidence of 510 
decreased accuracy. This improvement was seen during repetitions one, four and seven (70, 511 
100 and 140 minutes post-supplementation, respectively). Further evidence for a 512 
modulation of behaviour following the blackcurrant extracts comes from non-significant 513 
trends observed on the treatment*repetition ANOVAs for Bond-Lader alertness ratings and 514 
mental fatigue visual analogue scales showed. These indicated a pattern of attenuation in 515 
decreased self-reported alertness and increased ratings of fatigue following 516 
supplementation of the DelcyanTM treatment but only reached statistical significance after 517 
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the final repetition of the 70 minute attentionally demanding cognitive battery. Graphical 518 
representations of fatigue and alert ratings can be found in the supplementary materials. 519 
There is evidence of direct cellular and molecular interactions of flavonoids on rodent brains 520 
[22] and changes in central [23] and peripheral [20] vascular function in humans after 521 
consumption of flavonoid-rich fruits. However, definitive mechanisms driving the 522 
behavioural effects in the present study are currently unknown, especially after 523 
supplementation of the DelcyanTM treatment, which had no significant effect upon any of 524 
the physiological outcomes measured. 525 
As expected, blood plasma anthocyanins DEL-GLU, DEL-RUT, CY-GLU and CY-RUT 526 
were significantly increased 2.5 hours after supplementation of both blackcurrant 527 
treatments when compared to control. Measured blood plasma anthocyanins were also 528 
greater after supplementation of the DelcyanTM treatment when compared to the juice 529 
treatment. When all four measured anthocyanins were combined there was a 30% increase 530 
in plasma concentration following DelcyanTM when compared to the juice treatment. 531 
However, this extract contained 20% more of the measured anthocyanins than the juice 532 
drink. Although there was a significant difference in blood plasma anthocyanins between 533 
the two blackcurrant treatments, in line with past published research [20, 24, 25], 534 
anthocyanin quantities found in blood plasma were less than one percent of that ingested. 535 
It must be noted that vitamins and minerals, other than L-ascorbic were not quantified in 536 
any of the study treatments. However, to our knowledge there are no reported cognitive or 537 
behavioural effects of acute vitamin or mineral supplementation. Given that the major 538 
phenolic constituents of each treatment were anthocyanins and both extracts affected 539 
attention based tasks, this may indicate that the effects of blackcurrant upon attention 540 
processing are directly related to their anthocyanin content; an acute effect which has 541 
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previously been indicated in children aged 7-9 years [26]. The specific demands of the two 542 
attention tasks are, however, not equal, with a higher demand both in processing, and 543 
duration of the RVIP task when compared to the digit vigilance task. The RVIP contains a 544 
higher working memory element than the digit vigilance task, potentially indicating changes 545 
in working memory processing as well as attention, a cognitive outcome which has 546 
previously been shown to be sensitive to flavonoid-rich cocoa [27] and ginkgo biloba [28]. 547 
However, until replication of the behavioural effects presented in the current study has 548 
been achieved, it is difficult to elaborate further at this point. 549 
In terms of MAO-B activity, this is the first demonstration of a clinically significant 550 
inhibition of platelet MAO-B following blackcurrant supplementation. Central MAO-B 551 
inhibitors have been used for several decades for the treatment of depressive disorders and 552 
neurodegenerative diseases [29] and have also been shown to improve cognitive processing 553 
when given to non-demented Parkinson patients [30]. MAO-B inhibitors also have the 554 
potential to attenuate the breakdown of endogenous neurotransmitters, reducing levels of 555 
H2O2 associated with deamination of dopamine [31]. Although the current study only 556 
measured MAO-B inhibition in peripheral tissue, if the inhibition can be shown to be 557 
centrally active, the clinical applications of a MAO inhibitor from a commonly consumed 558 
fruit could be vast. Potential applications include attenuating cognitive decline associated 559 
with natural ageing, as well as in clinical populations, including those suffering from early 560 
stage Parkinson’s disease, whom are known to respond favourably to MAO inhibitors [30]. 561 
DHPG, a metabolite largely determined by MAO-A dependent metabolism of noradrenalin 562 
[32], which is a marker for reduced MAO-A activity after administration of pharmacological 563 
MAO-A inhibitors [33], was also found to be reduced after consumption of the Blackadder 564 
blackcurrant juice extract in the current study. This effect was not seen after consumption 565 
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of the DelcyanTM extract, highlighting that, in addition to MAO-B inhibition, the Blackadder 566 
juice treatment possesses MAO-A inhibitory properties. These changes in DHPG did not 567 
coincide with an accumulation of adrenalin or noradrenalin in the current study, which is in 568 
line with previous research investigating acute supplementation of MAO inhibitors in 569 
humans [34]. In addition to decreased levels of DHPG, indicating MAO-A inhibition, we also 570 
observed an increase in normetadrenalin, a metabolite of noradrenalin via catechol-O-571 
methyl transferase (COMT). This increase is potentially indicative of increased noradrenalin 572 
breakdown through COMT as a result of inhibition of the MAO-A enzyme. A diagram 573 
depicting potential inhibition pathways can be found in figure 6. Also related to this MAO 574 
inhibitory effect is a non-significant modulation of plasma prolactin observed in the current 575 
study where post-dose prolactin was lower after consumption of the Blackadder juice 576 
extract when compared to control. Although gamma-aminobutyric acid (GABA), serotonin, 577 
adrenalin and noradrenalin are slight rate limiting factors of prolactin secretion, dopamine is 578 
the most important hypothalamic prolactin inhibiting factor[35], indicating that general and 579 
potentially central dopaminergic tone could have been affected by supplementation of the 580 
Blackadder juice drink. Although these prolactin findings are hindered by a small sample size 581 
and between subjects design, they illuminate the need for further research. 582 
 583 
Place figure 6 here 584 
 585 
The blackcurrant juice treatment also showed a significant (over both time points) 586 
increase in blood glucose when compared to control, despite being sugar matched; an effect 587 
not seen with supplementation of the DelcyanTM treatment. Blood glucose was elevated by 588 
0.53mmo/L at 60 minutes and 0.23mmol/L at 150 minutes post supplementation of the 589 
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juice treatment. Although these results must be interpreted with caution as there were only 590 
two post-dose blood glucose measurements, this result shows a clear effect of the juice 591 
treatment on blood glucose. Based upon the current findings, the effect on glucose appears 592 
to resemble the pattern after supplementation of berry puree where  the peak in blood 593 
glucose levels following a glucose load when combined with a berry puree is reduced 594 
resulting in a higher blood glucose reading one hour after supplementation [36]. The main 595 
difference between the study treatments was phenolic acids at 0mg in the DelcyanTM 596 
treatment and 61mg in the juice treatment per 60kg of bodyweight, which could provide 597 
further evidence of the slowing of glucose transport from the gut via direct inhibition of 598 
intestinal epithelial glucose transporters by phenolic acids as described by Manzano and 599 
Williamson [8]. A more thorough investigation needs to be completed to ascertain a full 600 
post supplementation blood glucose profile. 601 
The findings of the present study demonstrate, for the first time, a positive 602 
modulation of behaviour in a young and healthy adult cohort after supplementation of a 603 
blackcurrant extract. This is also the first evidence of a clinically significant reduction in MAO 604 
activity following ingestion of a commonly consumed fruit. The results suggest that the MAO 605 
inhibition found in this study cannot be wholly responsible for the behavioural effects 606 
observed as both active conditions positively influenced attention based cognitive tasks, 607 
whereas only the juice treatment inhibited MAO-A and MAO-B. The finding of more robust 608 
effects on attention following DelcyanTM, containing higher levels of anthocyanins, may 609 
indicate that these effects are attributable to the anthocyanin content and that any effects 610 
on MAO are independent of these. The possibility that a MAO-A and MAO-B inhibiting 611 
blackcurrant drink will exert favourable effects on cognitive modulation of clinical and non-612 
clinical populations deserves further investigation. More exploration therefore needs to be 613 
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undertaken to ascertain if other cognitive paradigms, especially those which have previously 614 
been shown to be sensitive to flavonoid-rich nutritional interventions in rats and humans, 615 
specifically memory tasks and paradigms sensitive to changes in levels of dopamine, are 616 
modulated after supplementation of a MAO inhibiting blackcurrant juice.   617 
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